Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Vaxcyte (PCVX) Receivables - Net (2019 - 2025)

Vaxcyte (PCVX) has 7 years of Receivables - Net data on record, last reported at $400000.0 in Q3 2025.

  • On a quarterly basis, Receivables - Net rose 33.33% to $400000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $400000.0, a 33.33% increase, with the full-year FY2024 number at $400000.0, changed N/A from a year prior.
  • Receivables - Net reached $400000.0 in Q3 2025 per PCVX's latest filing, up from $100000.0 in the prior quarter.
  • Over the last five years, Receivables - Net for PCVX hit a ceiling of $5.0 million in Q3 2021 and a floor of $100000.0 in Q1 2022.
  • A 5-year average of $1.0 million and a median of $400000.0 in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: surged 525.0% in 2021, then tumbled 86.0% in 2022.
  • Tracing PCVX's Receivables - Net over 5 years: stood at $1.2 million in 2021, then decreased by 16.67% to $1.0 million in 2022, then soared by 90.0% to $1.9 million in 2023, then tumbled by 78.95% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • Business Quant data shows Receivables - Net for PCVX at $400000.0 in Q3 2025, $100000.0 in Q2 2025, and $400000.0 in Q4 2024.